Clinical Trials Logo

Clinical Trial Summary

AECOPD is a major cause of hospital admission and mortality. They contribute to long-term decline in lung function, physical capacity, and quality of life (QoL). RLS-0071 is a novel peptide being developed for the treatment of AECOPD. This study is designed to evaluate the safety and tolerability of RLS-0071 in the treatment of adults with moderate exacerbations of COPD.


Clinical Trial Description

This is a randomized, double-blind, placebo controlled trial in hospitalized participants with Acute Exacerbation of Chronic Obstructive Pulmonary Disease (AECOPD) to evaluate the safety, tolerability, preliminary efficacy, PK, and PD of RLS-0071 compared to Placebo in the treatment of AECOPD. The dosing regimen will be 3 times a day for at least 3 days and up to 5 days total if still hospitalized. Participants will be followed for efficacy and safety for 30 and 60 days after the final dose. RLS-0071 or Placebo will be given as add-on therapy to SOC management for acute exacerbations of COPD. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT06175065
Study type Interventional
Source ReAlta Life Sciences, Inc.
Contact Claire Whitaker
Phone 757-901-0322
Email cwhitaker@realtals.com
Status Recruiting
Phase Phase 2
Start date January 25, 2024
Completion date June 2024

See also
  Status Clinical Trial Phase
Completed NCT04044625 - Effects of High-intensity Noninvasive Positive Pressure Ventilation in AECOPD N/A
Active, not recruiting NCT03751670 - Pulmonary Rehabilitation During Acute Exacerbations of Chronic Obstructive Pulmonary Disease: a Mixed-methods Approach N/A
Completed NCT03083418 - The Effect of EDP on Diaphragmatic Function and Neural Respiratory Drive in Patient With AECOPD N/A
Recruiting NCT04183530 - The Individualized Accurate Diagnosis and Treatment of Chronic Objective Pulmonary Disease(COPD) Patients Based on Multidimensional Data
Enrolling by invitation NCT06189586 - Comparison of Aerosol Inhalation and Intravenous Glucocorticoid in the Treatment of Severe AECOPD N/A
Recruiting NCT06134063 - A Clinical Study on the Efficacy and Safety of Xuanfei Baidu Granule in the Treatment of Acute Exacerbation of Chronic Obstructive Pulmonary Disease N/A
Not yet recruiting NCT06114667 - Nasal High Flow Versus Non-invasive Ventilation for Early Treatment of Acute Exacerbation of Chronic Obstructive Pulmonary Disease With Hypercapnic Acidosis N/A
Not yet recruiting NCT05222711 - The Use of a Monitoring Device by General Practitioners During Out-of-hours Care N/A
Recruiting NCT05480566 - Functional Strength Training and Neuromuscular Electrical Stimulation in Severe Acute Exacerbations of COPD N/A
Terminated NCT02985918 - High-Intensity vs Low-Intensity NPPV in Patients With an AECOPD: The HAPPEN Trial N/A
Completed NCT04316312 - The Inspiratory Muscle Activation Pattern and Training Efficacy in Patients With Chronic Obstructive Pulmonary Disease After Acute Exacerbation N/A
Recruiting NCT04259736 - Prospective Cohort Study of Molecular Mechanism of Lower Respiratory Tract Microbes in Patients With AECOPD
Completed NCT03633838 - Clinical Outcome of Corticosteroids in the Treatment of COPD Exacerbations in China
Completed NCT02051166 - Clinical Practice of AECOPD Management in China N/A
Recruiting NCT04212182 - The Physiological Effect of High Flow Oxygen Therapy N/A
Not yet recruiting NCT06455670 - Effects of Chinese Medicine on Patients With Severe Acute Exacerbation of COPD N/A
Recruiting NCT04101500 - Effect of Compound Sodium Chlorate and Aminophylline Tablets on Chronic Obstructive Pulmonary Disease(COPD). Phase 4